| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.64.12.1443 |
| P8608 | Fatcat ID | release_t26gxdhqozejrhatcem6jofnru |
| P932 | PMC publication ID | 2581771 |
| P698 | PubMed publication ID | 18056553 |
| P5875 | ResearchGate publication ID | 5790778 |
| P50 | author | Bradley Hyman | Q23303113 |
| Marilyn S. Albert | Q56861968 | ||
| Deborah Blacker | Q66816378 | ||
| P2093 | author name string | Reisa A Sperling | |
| Bradford C Dickerson | |||
| P2860 | cites work | Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials | Q22253054 |
| “Mini-mental state” | Q25938989 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
| Neuropathologic features of amnestic mild cognitive impairment | Q28238965 | ||
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria | Q29614408 | ||
| Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
| The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 | ||
| Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease | Q30989943 | ||
| The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers | Q31081008 | ||
| Mild cognitive impairment represents early-stage Alzheimer disease | Q33938635 | ||
| Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q34244675 | ||
| Vitamin E and donepezil for the treatment of mild cognitive impairment | Q34411313 | ||
| Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience | Q34429537 | ||
| Current pharmacotherapy for Alzheimer's disease | Q34484065 | ||
| Medial temporal lobe function and structure in mild cognitive impairment | Q35105385 | ||
| Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders | Q35573431 | ||
| Mild cognitive impairment and dementia | Q36917790 | ||
| Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. | Q37299819 | ||
| Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 | ||
| Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man. | Q38499946 | ||
| Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study | Q39113668 | ||
| Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study | Q40349700 | ||
| The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study | Q40437287 | ||
| Brain imaging evidence of preclinical Alzheimer's disease in normal aging | Q45175819 | ||
| Neuropsychological measures in normal individuals that predict subsequent cognitive decline. | Q45950998 | ||
| A decade of pre-diagnostic assessment in a case of familial Alzheimer's disease: tracking progression from asymptomatic to MCI and dementia. | Q48945653 | ||
| Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. | Q48963534 | ||
| Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. | Q50758048 | ||
| Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. | Q51930296 | ||
| Mild cognitive impairment, amnestic type: an epidemiologic study. | Q51939291 | ||
| Neuropathologic substrate of mild cognitive impairment. | Q51985667 | ||
| The AD8: a brief informant interview to detect dementia. | Q51989396 | ||
| Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. | Q52003037 | ||
| The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease. | Q52021320 | ||
| A new clinical scale for the staging of dementia. | Q52220854 | ||
| A new rating scale for Alzheimer's disease. | Q53197509 | ||
| Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. | Q53231400 | ||
| Predicting conversion to Alzheimer disease using standardized clinical information. | Q53340763 | ||
| Mild cognitive impairment | Q57306293 | ||
| [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease | Q60451990 | ||
| Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease | Q73789480 | ||
| Preclinical prediction of AD using neuropsychological tests | Q74220290 | ||
| Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI | Q80071452 | ||
| Cognitive measures predict pathologic Alzheimer disease | Q83978028 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| mild cognitive impairment | Q1472703 | ||
| dementia | Q83030 | ||
| P304 | page(s) | 1443-1450 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment | |
| P478 | volume | 64 |
| Q64057622 | A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia |
| Q36316285 | APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts. |
| Q33832181 | ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia |
| Q48382487 | Affective symptoms as predictors of Alzheimer's disease in subjects with mild cognitive impairment: a 10-year follow-up study |
| Q64900979 | Alterations to task positive and task negative networks during executive functioning in Mild Cognitive Impairment. |
| Q36991856 | Alzheimer disease alters the relationship of cardiorespiratory fitness with brain activity during the stroop task |
| Q35428425 | Amnestic mild cognitive impairment and early Alzheimer's disease in an asian memory clinic - evidence for a clinical spectrum |
| Q35927059 | An investigation of PreMCI: subtypes and longitudinal outcomes |
| Q34318022 | Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions |
| Q35043632 | Atrophy in distinct corticolimbic networks in frontotemporal dementia relates to social impairments measured using the Social Impairment Rating Scale |
| Q38416584 | Biochemical and neuroimaging studies in subjective cognitive decline: progress and perspectives. |
| Q38858239 | Biomarkers and Functional Decline in Prodromal Alzheimer's Disease |
| Q64109130 | Breadth and depth of working memory and executive function compromises in mild cognitive impairment and their relationships to frontal lobe morphometry and functional competence |
| Q46381464 | Cardiopulmonary fitness is associated with cognitive performance in patients with coronary artery disease |
| Q40073243 | Clinical Dementia Rating independently predicted conversion to dementia in a cohort of urban elderly in Brazil. |
| Q92583995 | Clinical Predictors for Mild Cognitive Impairment Progression in a Korean Cohort |
| Q45995023 | Clinical utility of the hopkins Verbal Test-Revised for detecting Alzheimer's disease and mild cognitive impairment in Spanish population. |
| Q47120007 | Cluster analysis of cognitive performance in a sample of patients with Parkinson's disease |
| Q51948130 | Cognitive abilities and functional capacity in older adults: results from the modified Scales of Independent Behavior-Revised. |
| Q38603323 | Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort |
| Q37606844 | Cognitive complaints in older adults at risk for Alzheimer's disease are associated with altered resting-state networks |
| Q35649175 | Comparison of regional gray matter atrophy, white matter alteration, and glucose metabolism as a predictor of the conversion to Alzheimer's disease in mild cognitive impairment. |
| Q34054940 | Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia |
| Q37060357 | Decreased Self-Appraisal Accuracy on Cognitive Tests of Executive Functioning Is a Predictor of Decline in Mild Cognitive Impairment |
| Q37073537 | Decreased cognitive function in extended family members from the single late-onset-Alzheimer's-disease pedigree |
| Q41155850 | Determinants of Activity Levels in African Americans With Mild Cognitive Impairment |
| Q33650931 | Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. |
| Q50059051 | Diagnosed dementia and the risk of motor vehicle crash among older drivers |
| Q50983678 | Differential diagnosis of depression and Alzheimer's disease using the Cattell-Horn-Carroll theory. |
| Q50779605 | Estimation of the risk of conversion of mild cognitive impairment of Alzheimer type to Alzheimer's disease in a south Brazilian population-based elderly cohort: the PALA study. |
| Q59335109 | Event-Related Potentials Reveal Altered Executive Control Activity in Healthy Elderly With Subjective Memory Complaints |
| Q33721909 | Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease |
| Q27009241 | Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's disease |
| Q34554125 | Failure of repetition suppression and memory encoding in aging and Alzheimer's disease |
| Q35579221 | For debate: substituting placebo controls in long-term Alzheimer's prevention trials |
| Q37601466 | Four-year outcome of mild cognitive impairment: the contribution of executive dysfunction. |
| Q34565270 | Functional alterations in memory networks in early Alzheimer's disease |
| Q97652819 | Genome-wide association study of cognitive function in diverse Hispanics/Latinos: results from the Hispanic Community Health Study/Study of Latinos |
| Q33881832 | Group-Level Progressive Alterations in Brain Connectivity Patterns Revealed by Diffusion-Tensor Brain Networks across Severity Stages in Alzheimer's Disease |
| Q34076179 | Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease |
| Q37194883 | Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline |
| Q47831657 | Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms. |
| Q37190009 | Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints |
| Q33511725 | Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging |
| Q37424713 | Linking hippocampal structure and function to memory performance in an aging population |
| Q35859085 | Literacy Independent Cognitive Assessment: Assessing Mild Cognitive Impairment in Older Adults with Low Literacy Skills |
| Q36304533 | MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults |
| Q35116519 | Measuring cognitive reserve based on the decomposition of episodic memory variance |
| Q39250175 | Mild cognitive impairment: searching for the prodrome of Alzheimer's disease |
| Q33817209 | Modeling and Estimating Recall Processing Capacity: Sensitivity and Diagnostic Utility in Application to Mild Cognitive Impairment |
| Q36672521 | Multiple Brain Markers are Linked to Age-Related Variation in Cognition |
| Q47146178 | Neuropsychological performance differences between two groups of probable-AD patients from different areas of Brazil |
| Q60043911 | Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease: a feature selection ensemble combining stability and predictability |
| Q35878768 | Neuropsychological tests for predicting cognitive decline in older adults |
| Q89431968 | Normative performance of healthy older individuals on the Modified Mini-Mental State (3MS) examination according to ethno-racial group, gender, age, and education level |
| Q34714070 | Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. |
| Q36445708 | P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia |
| Q38479624 | Performance on the RI-48 Cued Recall Test Best Predicts Conversion to Dementia at the 5- and 10-Year Follow-Ups |
| Q35218921 | Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. |
| Q38655025 | Predicting progression of mild cognitive impairment to dementia using neuropsychological data: a supervised learning approach using time windows. |
| Q33816135 | Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data |
| Q34162212 | Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study |
| Q37136330 | Principal components methods for narrow-sense heritability in the analysis of multidimensional longitudinal cognitive phenotypes |
| Q28389799 | Recognition of famous names predicts cognitive decline in healthy elders |
| Q36177038 | Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia |
| Q34180267 | SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment |
| Q35857678 | Specific measures of executive function predict cognitive decline in older adults |
| Q36322792 | Subjective cognitive complaints and amyloid burden in cognitively normal older individuals |
| Q34090664 | Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease |
| Q36198927 | Subjective memory complaints, cognitive performance, and psychological factors in healthy older adults |
| Q37733987 | Tau oligomers in cerebrospinal fluid in Alzheimer's disease |
| Q33625660 | The Combination of Dysexecutive and Amnestic Deficits Strongly Predicts Conversion to Dementia in Young Mild Cognitive Impairment Patients: A Report from the Gothenburg-Oslo MCI Study |
| Q50590724 | The Effect of Psychological Distress and Personality Traits on Cognitive Performances and the Risk of Dementia in Patients with Mild Cognitive Impairment. |
| Q35670260 | The SIST-M: predictive validity of a brief structured clinical dementia rating interview |
| Q34681067 | The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview |
| Q36191996 | The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. |
| Q37180370 | The cortical signature of prodromal AD: regional thinning predicts mild AD dementia |
| Q34807653 | The fate of the 0.5s: predictors of 2-year outcome in mild cognitive impairment |
| Q47626911 | The prevalence and progression of mild cognitive impairment among clinic and community populations: a systematic review and meta-analysis. |
| Q37408596 | The thickness of posterior cortical areas is related to executive dysfunction in Alzheimer's disease |
| Q50673180 | The unbearable lightness of MCI. |
| Q35153431 | The urban neighborhood and cognitive functioning in late middle age |
| Q43011388 | Use of the Progressive Aphasia Severity Scale (PASS) in monitoring speech and language status in PPA. |
| Q50545946 | Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS). |
| Q37573775 | Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up |
| Q37086723 | Which neuropsychological tests predict progression to Alzheimer's disease in Hispanics? |
| Q33864697 | White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. |
Search more.